TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $60,000 | +39.5% | 3,608 | -64.6% | 0.00% | – |
| Q2 2022 | $43,000 | -10.4% | 10,190 | +102.3% | 0.00% | – |
| Q1 2022 | $48,000 | -50.0% | 5,038 | 0.0% | 0.00% | – |
| Q4 2021 | $96,000 | -30.4% | 5,038 | +21.1% | 0.00% | – |
| Q3 2021 | $138,000 | +23.2% | 4,160 | +44.3% | 0.00% | – |
| Q2 2021 | $112,000 | -19.4% | 2,883 | 0.0% | 0.00% | – |
| Q1 2021 | $139,000 | +2.2% | 2,883 | +10.0% | 0.00% | – |
| Q4 2020 | $136,000 | +94.3% | 2,622 | 0.0% | 0.00% | – |
| Q3 2020 | $70,000 | +37.3% | 2,622 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | +2450.0% | 2,622 | +424.4% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -99.7% | 500 | -99.3% | 0.00% | -100.0% |
| Q2 2018 | $889,000 | +19.8% | 67,601 | +29.4% | 0.00% | +100.0% |
| Q1 2018 | $742,000 | – | 52,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |